SEC Filing Details

SEC Filing Details

Document Details

Form
424B3
Filing Date
Mar 29, 2019
Document Date
Mar 29, 2019
Form Description
Form of prospectus reflecting facts events constituting substantive change from last form
Filing Group
Registration Statements
Company
ReShape Lifesciences
Issuer
For investor inquiries, please contact:

ReShape Lifesciences Investor Contact:
Thomas Stankovich
Chief Financial Officer
949-276-6042
ir@ReShapeLifesci.com

Investor Contacts:
Rx Communications Group
Michael Miller
917-633-6086
mmiller@rxir.com

PRINT PAGE

EMAIL PAGE